OOIR: Observatory of International Research

Papers

(The H4-Index of JACC: Cardiooncology is 28. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-03-01 to 2024-03-01.)

Article	Citations
Cardiac Tumors	182
Cardiovascular Effects of CAR T Cell Therapy	76
Cardiovascular Risk Factors Are Associated With Future Cancer	74
Cardiovascular Manifestations From Therapeutic Radiation	71
Past, Present, and Future of Radiation-Induced Cardiotoxicity: Refinements in Targeting, Surveillance, and Risk Stratification	70
The Novel Coronavirus Disease (COVID-19) Threat for Patients With Cardiovascular Disease and Cancer	70
The Evolving Immunotherapy Landscape and the Epidemiology, Diagnosis, and Management of Cardiotoxicity	67
Venous and Arterial Thromboembolism in Patients With Cancer	66
CAR T Cell Therapy–Related Cardiovascular Outcomes and Management	64
Immune Checkpoint Inhibitor Therapy Aggravates T Cell–Driven Plaque Inflammation in Atherosclerosis	62
ATTR Amyloidosis: Current and Emerging Management Strategies	54
Incident Cardiovascular Disease Among Adults With Cancer	49
Strain Imaging in Cardio-Oncology	49
Risk of Atrial Fibrillation According to Cancer Type	49
Common Pathophysiology in Cancer, Atrial Fibrillation, Atherosclerosis, and Thrombosis	47
Early Cardiac Toxicity Associated With Post-Transplant Cyclophosphamide in Allogeneic Stem Cell Transplantation	46
Myocarditis Surveillance With High-Sensitivity Troponin I During Cancer Treatment With Immune Checkpoint Inhibitors	46
The Role of Cardioprotection in Cancer Therapy Cardiotoxicity	45
Direct Oral Anticoagulants in Patients With Active Cancer	40
Mitochondria-Rich Extracellular Vesicles Rescue Patient-Specific Cardiomyocytes From Doxorubicin Injury	39
Cardiac Adverse Events in EGFR-Mutated Non-Small Cell Lung Cancer Treated With Osimertinib	36
BSE and BCOS Guideline for Transthoracic Echocardiographic Assessment of Adult Cancer Patients Receiving Anthracyclines and/or Trastuzumab	33
Diuretic Dose and NYHA Functional Class Are Independent Predictors of Mortality in Patients With Transthyretin Cardiac Amyloidosis	32
Cardiac Disease in Childhood Cancer Survivors	32
Genetics of Anthracycline Cardiomyopathy in Cancer Survivors	31

Early Detection and Prediction of Anthracycline-Induced Right Ventricular Cardiotoxicity by 3-Dimensional Echocardiography	30
Doxorubicin-Induced Oxidative Stress and Endothelial Dysfunction in Conduit Arteries Is Prevented by Mitochondrial-Specific Antioxidant Treatment	29
Dual Angiotensin Receptor-Neprilysin Inhibition With Sacubitril/Valsartan Attenuates Systolic Dysfunction in Experimental Doxorubicin-Induced Cardiotoxicity	28
Arterial Thromboembolism in Cancer Patients	28